Reply to "The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real world"
| dc.citation.epage | 1039 | en_US |
| dc.citation.spage | 1038 | en_US |
| dc.citation.volume | 117 | en_US |
| dc.citation.woscount | 0 | en_US |
| dc.contributor.author | Yu, Ming-Lung | en_US |
| dc.contributor.department | 生物科技學院 | zh_TW |
| dc.contributor.department | College of Biological Science and Technology | en_US |
| dc.date.accessioned | 2019-04-02T05:59:50Z | |
| dc.date.available | 2019-04-02T05:59:50Z | |
| dc.date.issued | 2018-11-01 | en_US |
| dc.identifier.doi | 10.1016/j.jfma.2018.09.014 | en_US |
| dc.identifier.issn | 0929-6646 | en_US |
| dc.identifier.journal | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION | en_US |
| dc.identifier.uri | http://dx.doi.org/10.1016/j.jfma.2018.09.014 | en_US |
| dc.identifier.uri | https://ir.lib.nycu.edu.tw/handle/11536/148349 | |
| dc.identifier.wosnumber | WOS:000448023100016 | en_US |
| dc.language.iso | en_US | en_US |
| dc.title | Reply to "The choice of antiviral therapy for hepatitis C recurrence after liver transplantation in the real world" | en_US |
| dc.type | Article | en_US |